Cargando…
Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
Recent evidence suggests that splicing factors (SFs) and alternative splicing (AS) play important roles in cancer progression. We constructed four SF-risk-models using 12 survival-related SFs. In Luminal-A, Luminal-B, Her-2, and Basal-Like BRCA, SF-risk-models for three genes (PAXBP1, NKAP, and NCBP...
Autores principales: | Zhang, He, Han, Baoai, Han, Xingxing, Zhu, Yuying, Liu, Hui, Wang, Zhiyong, Cui, Yanfen, Tian, Ran, Gao, Zicong, Tian, Ruinan, Ren, Sixin, Zuo, Xiaoyan, Tian, Jianfei, Zhang, Fei, Niu, Ruifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497829/ https://www.ncbi.nlm.nih.gov/pubmed/34630526 http://dx.doi.org/10.3389/fgene.2021.736423 |
Ejemplares similares
-
Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer
por: Zhang, He, et al.
Publicado: (2023) -
Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes
por: Han, Baoai, et al.
Publicado: (2020) -
Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling
por: Han, Baoai, et al.
Publicado: (2022) -
Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy
por: Zuo, Xiaoyan, et al.
Publicado: (2022) -
Mitochondrial Breast Cancer Resistant Protein Sustains the Proliferation and Survival of Drug-Resistant Breast Cancer Cells by Regulating Intracellular Reactive Oxygen Species
por: Zhang, He, et al.
Publicado: (2021)